Critical support for HIghly aged patients with BAsal insulin plus One oral therapy

Not Applicable

• Conditions: type 2 diabetes

• Registration Number: JPRN-UMIN000007192
• Lead Sponsor: The jikei University School of Medicine

Brief Summary

There were only three patients included.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-04-01
• Study Completion: 2013-12-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

Patients who are ketosis-prone, have advanced renal failure or nephritic syndrome, proliferative retinopathy, severe cardiac disease, liver damage, and also who have active malignancies with poor prognosis. Patients who are impossible to do the self-injection therapy nor answer to the DTQS by themselves. Patients whom the doctors would judge as inappropriate for the inclusion should also be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood glucose-lowering effect to the target level and QOL satisfaction in elderly patients without any severe problem in management of diabetesby one-daily long acting insulin and once-daily oral agents

Secondary Outcome Measures

Name	Time	Method
Improvement of laboratory data including HbA1c, 1,5-AG and FPG, of frequency of hypoglycemia during the trial, and of the QOL score (Diabetes Treatment Satisfaction Questionnaire:DTSQ).